# Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium

> **NCT07427446** · PHASE4 · RECRUITING · sponsor: **Kasr El Aini Hospital** · enrollment: 50 (estimated)

## Conditions studied

- Emergence Delirium

## Interventions

- **DRUG:** Dexmedetomidine and Midazolam
- **DRUG:** Ketamine and Midazolam

## Key facts

- **NCT ID:** NCT07427446
- **Lead sponsor:** Kasr El Aini Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07427446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07427446, "Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07427446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*